Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2003
09/04/2003WO2003044187A3 Emulsion compositions
09/04/2003WO2003036267A3 Filtration system and method for obtaining a cytology layer
09/04/2003WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2003030129A3 Labelled articles and uses thereof
09/04/2003WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/04/2003WO2003027635A3 Detection of fusarium species infecting corn using the polymerase chain reaction
09/04/2003WO2003027225A3 Regulation of human steroid 5-alpha reductase
09/04/2003WO2003018765A3 A high throughput method for identification of sequence tags
09/04/2003WO2003014366A3 Rna amplification system using plant components in animal cells
09/04/2003WO2003014151A3 Human secreted proteins, their encoding polynucleotides, and uses thereof
09/04/2003WO2003005890A3 Affinity biosensor for monitoring of biological process
09/04/2003WO2003001212A3 A method for diagnosing a person having multiple sclerosis
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003WO2002101017A3 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
09/04/2003WO2002099130A3 Virus detection using degenerate pcr primers
09/04/2003WO2002097435A3 Assay method for platelet-activating factor
09/04/2003WO2002097395A3 P-cadherin as a target for anti-cancer therapy
09/04/2003WO2002083853A3 Method for enhancing the translation and expression of recombinant proteins
09/04/2003WO2002081749A3 Detection of aberrant dna methylation as marker for human cancer
09/04/2003WO2002081656A3 Enhanced diagnostic potential of prostate-specific antigen expressing cells
09/04/2003WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof
09/04/2003WO2002070703A3 Cell visual characteristic-modifying sequences
09/04/2003WO2002066952A3 Mass defect labeling for the determination of oligomer sequences
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002063049A3 Methods for determining a nucleotide at a specific location within a nucleic acid molecule
09/04/2003WO2002061124A3 Analysis of methylation patterns in genomic dna using bisulfite treatment and fluorescence polarisation assay techniques
09/04/2003WO2002061079A3 Biligands
09/04/2003WO2002061041A3 Solubility reporter gene constructs
09/04/2003WO2002057493A3 Methods for determining organisms
09/04/2003WO2002055742A3 Rapid method for screening compounds for in vivo activity
09/04/2003WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation
09/04/2003WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression
09/04/2003WO2002048396A3 Sensor for detecting macromolecular biopolymers
09/04/2003WO2002046472A3 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002046353A3 Self-spreading microbiological culture device
09/04/2003WO2002040995A3 Method for estimating metabolic function of xenobiotic and induction thereof
09/04/2003WO2002036807A3 Compositions and methods relating to breast specific genes and proteins
09/04/2003WO2002036770A3 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
09/04/2003WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
09/04/2003WO2002032928A3 Haplotypes of the hrh1 gene
09/04/2003WO2002031484A8 Methods for characterizing molecular interactions using affinity capture tandem mass spectrometry
09/04/2003WO2002031166A3 Artificial transcriptional factors and methods of use
09/04/2003WO2002029103A3 Gene expression profiles in liver cancer
09/04/2003WO2002029094A3 Method of selection, by two-dimensional separation, of nucleic acids that bind to a target with high affinity
09/04/2003WO2002022870A3 Method for the characterization and/or identification of genomes
09/04/2003WO2002020769A9 Human and mouse targeting peptides identified by phage display
09/04/2003WO2002018643A3 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/04/2003WO2002016935A9 Screening method for discovering auxiliary agents promoting endocytosis
09/04/2003WO2002010741A3 Regional intestinal permeability model
09/04/2003WO2002010458A3 Method of performing subtractive hybridization
09/04/2003WO2002008456A3 Method for identifying metastatic tumor cells
09/04/2003WO2002002808A3 Method and nucleic acids for the analysis of astrocytomas
09/04/2003WO2002000932A3 Diagnosis of known genetic parameters within the mhc
09/04/2003WO2001098765A9 Multianalyte molecular analysis
09/04/2003WO2001096605A3 Methods of dissociating nongenotropic from genotropic activity of steroid receptors
09/04/2003WO2001094629A3 Cancer gene determination and therapeutic screening using signature gene sets
09/04/2003WO2001090416A3 Methods and compositions for preparation of a polynucleotide array
09/04/2003WO2001086002A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
09/04/2003WO2001081622A3 Diagnosis of diseases associated with dna repair
09/04/2003WO2001076451A3 Diagnosis of diseases associated with metabolism
09/04/2003WO2001066799A3 Real time quantitative pcr with intercalating dye for single and multiplex target dna
09/04/2003WO2001066595A9 Human fgf-23 gene and gene expression products
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003WO2001055720A3 A system for developing assays for personalized medicine
09/04/2003US20030167538 Genetic engineered plants; corn, wheat, rice
09/04/2003US20030167536 Plant adpglucose pyroghophatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants
09/04/2003US20030167527 Transgenic plant; genetic engineering
09/04/2003US20030167522 Obtained from Bacillus thuringiensis (cry proteins); for activity against corn rootworm pests
09/04/2003US20030167521 Genetic engineered insecticide
09/04/2003US20030167512 Method of determining the presence of a trait in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in a positive orientation
09/04/2003US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences
09/04/2003US20030167495 Comprises spinocerebellar ataxias (SCAs) genes; neurodegenerative disorders; homologous recombination; genes
09/04/2003US20030167487 Homologous recombination; stem cells; drug screening; platelets
09/04/2003US20030167486 Double transgenic mice overexpressing human beta secretase and human APP-London
09/04/2003US20030167480 Diagnosis, therapy of cancer using antibodies; detcting, calibration binding
09/04/2003US20030167135 Non-linear modelling of biological activity of chemical compounds
09/04/2003US20030167134 Determination radiation; biological warfare; culture product; polymerase chain reactions
09/04/2003US20030167133 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
09/04/2003US20030166917 Purification by chromatography, ion exchanging, analyzing
09/04/2003US20030166915 Retrovirus from the HIV group and its use
09/04/2003US20030166911 Hybrid nucleic acids; genetic engineering
09/04/2003US20030166908 Seafood protein; measuring water absorption of fish bladder
09/04/2003US20030166903 Genes associated with vascular disease
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166897 Diagnosis, therapy cancer; transgenic animal
09/04/2003US20030166896 Polynucleotide containing phosphoramidite group
09/04/2003US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders
09/04/2003US20030166891 Novel Bt toxin receptors from lepidopteran insects and methods of use
09/04/2003US20030166862 Purified mammalian CTLA-8 antigens and related reagents
09/04/2003US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents
09/04/2003US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound
09/04/2003US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
09/04/2003US20030166847 Novel human leptin receptor gene-related protein
09/04/2003US20030166832 Methods and compositions for impairing multiplication of HIV-1
09/04/2003US20030166599 Uses of tgap7 for the modulation of leucocyte activation
09/04/2003US20030166587 Compounds and methods for modulating activation of NF-kB
09/04/2003US20030166568 Organic compounds
09/04/2003US20030166562 Treatment for asthma or allergies
09/04/2003US20030166554 Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists